• 1007 Citations
  • 17 Scopus h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2005 2019

Filter
Article
2006
26 Citations (Scopus)

Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer

Ailawadhi, S., Sunga, A., Rajput, A., Yang, G. Y., Smith, J. & Fakih, M., Mar 2006, In : Oncology. 70, 1, p. 49-53 5 p.

Research output: Contribution to journalArticle

Carcinoembryonic Antigen
Colorectal Neoplasms
Drug Therapy
Incidence
Neoplasms
2007
3 Citations (Scopus)

Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma

Ailawadhi, S., Nagase, H., Khoury, T., Yu, J., Tan, D., Black, J., Brattain, M. & Javle, M., Jul 2007, In : Hepato-Gastroenterology. 54, 77, p. 1339-1344 6 p.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Extracellular Signal-Regulated MAP Kinases
Biliary Tract Neoplasms
Epidemiology
Cytoprotection
47 Citations (Scopus)

Serotonin syndrome caused by interaction between citalopram and fentanyl

Ailawadhi, S., Sung, K. W., Carlson, L. A. & Baer, M. R., Apr 2007, In : Journal of Clinical Pharmacy and Therapeutics. 32, 2, p. 199-202 4 p.

Research output: Contribution to journalArticle

Serotonin Syndrome
Citalopram
Fentanyl
Neurologic Gait Disorders
Pain
2009
25 Citations (Scopus)

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: Results of a phase II clinical trial

Chanan Khan, A. A., Miller, K. C., Musial, L., Padmanabhan, S., Yu, J., Ailawadhi, S., Sher, T., Mohr, A., Bernstein, Z. P., Barcos, M., Patel, M., Iancu, D., Lee, K. & Czuczman, M. S., 2009, In : Leukemia and Lymphoma. 50, 7, p. 1096-1101 6 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Thalidomide
Multiple Myeloma
Steroids
Plasma Cells
9 Citations (Scopus)

Erlotinib for metastatic non-small-cell lung cancer: First-, second- or third-line setting - Does it matter? A single-institution experience

Ailawadhi, S., Derby, L., Natarajan, R., Fetterly, G., Reid, M. & Ramnath, N., Feb 2009, In : Oncology. 76, 2, p. 85-90 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Erlotinib Hydrochloride
Therapeutics
Prescriptions
2010
13 Citations (Scopus)

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma

Ailawadhi, S., Abdelhalim, A. N., Derby, L., Mashtare, T. L., Miller, K. C., Wilding, G. E., Alberico, R. A., Gottlieb, R., Klippenstein, D. L., Lee, K. & Chanan Khan, A. A., Jan 1 2010, In : Cancer. 116, 1, p. 84-92 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Marrow
Magnetic Resonance Imaging
Survival
Salmon
3 Citations (Scopus)

Treatment options for multiple myeloma patients with high-risk disease

Ailawadhi, S., Masood, A., Sher, T., Miller, K. C., Wood, M., Lee, K. & Chanan Khan, A. A., Jun 2010, In : Medical Oncology. 27, SUPPL. 1

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Therapeutics
Biological Factors
Clinical Trials
2011
11 Citations (Scopus)

A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients

Sher, T., Ailawadhi, S., Miller, K. C., Manfredi, D., Wood, M., Tan, W., Wilding, G., Czuczman, M. S., Hernandez-Ilizaliturri, F. J., Hong, F., Sood, R., Soniwala, S., Lawrence, W., Jamshed, S., Masood, A., Iancu, D., Lee, K. & Chanan Khan, A. A., Jul 2011, In : British Journal of Haematology. 154, 1, p. 104-110 7 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Steroids
Drug Combinations
Constipation
2012
14 Citations (Scopus)

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

Ailawadhi, S., Miecznikowski, J., Gaile, D. P., Wang, D., Sher, T., Mulligan, G., Bryant, B., Wilding, G. E., Mashtare, T., Stein, L., Masood, A., Neuwirth, R., Lee, K. P. & Chanan Khan, A. A., Jun 2012, In : Leukemia and Lymphoma. 53, 6, p. 1174-1182 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
bcl-2 Genes
Apoptosis Regulatory Proteins
Dexamethasone
Proteins
19 Citations (Scopus)

Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

Masood, A., Chitta, K., Paulus, A., Khan, A. N. H., Sher, T., Ersing, N., Miller, K. C., Manfredi, D., Ailawadhi, S., Borrelo, I., Lee, K. P. & Chanan Khan, A. A., Apr 2012, In : British Journal of Haematology. 157, 1, p. 59-66 8 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Down-Regulation
Therapeutics
Antibodies
Immunologic Factors
40 Citations (Scopus)

Outcome disparities in multiple myeloma: A SEER-based comparative analysis of ethnic subgroups

Ailawadhi, S., Aldoss, I. T., Yang, D., Razavi, P., Cozen, W., Sher, T. & Chanan Khan, A. A., Jul 2012, In : British Journal of Haematology. 158, 1, p. 91-98 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Epidemiology
Survival
Hispanic Americans
Registries
2013
16 Citations (Scopus)

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute- Waldenström Macroglobulinemia 1

Chitta, K. S., Paulus, A., Ailawadhi, S., Foster, B. A., Moser, M. T., Starostik, P., Masood, A., Sher, T., Miller, K. C., Iancu, D. M., Conroy, J., Nowak, N. J., Sait, S. N., Personett, D. A., Coleman, M., Furman, R. R., Martin, P., Ansell, S. M., Lee, K. & Chanan Khan, A. A., Feb 2013, In : Leukemia and Lymphoma. 54, 2, p. 387-396 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cell Line
Neoplasms
Immunoglobulin Heavy Chains
Tumor Cell Line
34 Citations (Scopus)

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics

Razavi, P., Rand, K. A., Cozen, W., Chanan Khan, A. A., Usmani, S. & Ailawadhi, S., Jun 2013, In : Blood Cancer Journal. 3, 6, e121.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Multiple Myeloma
Confidence Intervals
Therapeutics
Incidence
8 Citations (Scopus)

Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management

Guiang, K. M. U., Cantey, P., Montgomery, S. P., Ailawadhi, S., Qvarnstrom, Y., Price, T. & Blodget, E., Dec 2013, In : Transplant Infectious Disease. 15, 6

Research output: Contribution to journalArticle

Chagas Disease
Bone Marrow
Transplants
Transplantation
Stem Cells
2014
2 Citations (Scopus)

Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma

Siddiqi, I. N., Ailawadhi, S., Huang, Q., Shibata, R. K., Kang, H. & Shibata, D., 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 3

Research output: Contribution to journalArticle

Clonal Evolution
High-Throughput Nucleotide Sequencing
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Young Adult
13 Citations (Scopus)

Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia

Chitta, K., Paulus, A., Caulfield, T., Akhtar, S., Blake, M. K. K., Ailawadhi, S., Knight, J., Heckman, M. G., Pinkerton, A. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 11, e260.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Apoptosis
Limonins
Neoplasms
Computer Simulation
12 Citations (Scopus)

Outcome disparities among ethnic subgroups of waldenström's macroglobulinemia: A population-based study

Ailawadhi, S., Kardosh, A., Yang, D., Cozen, W., Patel, G., Alamgir, M. A. & Chanan Khan, A. A., 2014, In : Oncology (Switzerland). 86, 5-6, p. 253-262 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
African Americans
Population
Health Resources
Marital Status
10 Citations (Scopus)

Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma

Kim, M. Y., Sposto, R., Swaika, A., Asano, H., Alamgir, A., Chanan Khan, A. A. & Ailawadhi, S., Nov 7 2014, In : Oncology (Switzerland). 87, 4, p. 224-231 8 p.

Research output: Contribution to journalArticle

Pharmaceutical Economics
Melphalan
Multiple Myeloma
Prednisone
Costs and Cost Analysis
8 Citations (Scopus)

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Ailawadhi, S., Swaika, A., Razavi, P., Yang, D. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 9, e243.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Multiple Myeloma
Incidence
Epidemiology
Survival
2015
14 Citations (Scopus)

Financial burden after allogeneic hematopoietic cell transplantation: A qualitative analysis from the patient's perspective

Kim, W., McNulty, J., Chang, Y. H., Weise, M., Hashmi, S., Ailawadhi, S. & Khera, N. D., Sep 4 2015, In : Bone Marrow Transplantation. 50, 9, p. 1259-1261 3 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: Potential biological and therapeutic implications

Paulus, A., Chitta, K. S., Wallace, P. K., Advani, P. P., Akhtar, S., Kuranz-Blake, M., Ailawadhi, S. & Chanan Khan, A. A., Apr 8 2015, In : PLoS One. 10, 4, e0122338.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunophenotyping
surface antigens
Surface Antigens
Cells
11 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Epidemiology
B-Lymphocytes
28 Citations (Scopus)
Waldenstrom Macroglobulinemia
Apoptosis
Proteasome Endopeptidase Complex
Neoplasms
Ubiquitinated Proteins
58 Citations (Scopus)

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Consensus
Expert Testimony
Therapeutics
2016
7 Citations (Scopus)

A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci

Rand, K. A., Song, C., Dean, E., Serie, D. J., Curtin, K., Sheng, X., Hu, D., Huff, C. A., Bernal-Mizrachi, L., Tomasson, H. M., Ailawadhi, S., Singhal, S., Pawlish, K., Peters, E. S., Bock, C. H., Stram, A., Van Den Berg, D. J., Edlund, C. K., Conti, D. V., Zimmerman, T. & 82 others, Hwang, A. E., Huntsman, S., Graff, J., Nooka, A., Kong, Y., Pregja, S. L., Berndt, S. I., Blot, W. J., Carpten, J., Casey, G., Chu, L., Diver, W. R., Stevens, V. L., Lieber, M. R., Goodman, P. J., Hennis, A. J. M., Hsing, A. W., Mehta, J., Kittles, R. A., Kolb, S., Klein, E. A., Leske, C., Murphy, A. B., Nemesure, B., Neslund-Dudas, C., Strom, S. S., Vij, R., Rybicki, B. A., Stanford, J. L., Signorello, L. B., Witte, J. S., Ambrosone, C. B., Bhatti, P., John, E. M., Bernstein, L., Zheng, W., Olshan, A. F., Hu, J. J., Ziegler, R. G., Nyante, S. J., Bandera, E. V., Birmann, B. M., Ingles, S. A., Press, M. F., Atanackovic, D., Glenn, M. J., Cannon-Albright, L. A., Jones, B., Tricot, G., Martin, T. G., Kumar, S. K., Wolf, J. L., Deming Halverson, S. L., Rothman, N., Brooks-Wilson, A. R., Rajkumar, S. V., Kolonel, L. N., Chanock, S. J., Slager, S. L., Severson, R. K., Janakiraman, N., Terebelo, H. R., Brown, E. E., De Roos, A. J., Mohrbacher, A. F., Colditz, G. A., Giles, G. G., Spinelli, J. J., Chiu, B. C., Munshi, N. C., Anderson, K. C., Levy, J., Zonder, J. A., Orlowski, R. Z., Lonial, S., Camp, N. J., Vachon, C. M., Ziv, E., Stram, D. O., Hazelett, D. J., Haiman, C. A. & Cozen, W., Dec 1 2016, In : Cancer Epidemiology Biomarkers and Prevention. 25, 12, p. 1609-1618 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Meta-Analysis
Population
NF-kappa B
Tumor Necrosis Factor Receptors
15 Citations (Scopus)

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Paulus, A., Akhtar, S., Caulfield, T., Samuel, K., Yousaf, H., Bashir, Y., Paulus, S. M., Tran, D., Hudec, R., Cogen, D., Jiang, J., Edenfield, B., Novak, A. J., Ansell, S. M., Witzig, T. E., Martin, P., Coleman, M., Roy, V., Ailawadhi, S., Chitta, K. & 2 others, Linder, S. & Chanan Khan, A. A., Nov 4 2016, In : Blood Cancer Journal. 6, 11, e492.

Research output: Contribution to journalArticle

Ubiquitin-Specific Proteases
Waldenstrom Macroglobulinemia
Hydrolases
Ubiquitin
Isoenzymes
53 Citations (Scopus)

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Tumors
Immunity
Apoptosis
Neoplasms
8 Citations (Scopus)

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Multiple Myeloma
Registries
Neoplasms
Survival
30 Citations (Scopus)

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J. R., Stewart, A. K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. M. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Proteasome Inhibitors
6 Citations (Scopus)

Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma

Sahu, K. K., Gautam, A. & Ailawadhi, S., Nov 4 2016, (Accepted/In press) In : Clinical Nuclear Medicine.

Research output: Contribution to journalArticle

Myeloid Sarcoma
2017
1 Citation (Scopus)

Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion

Waddle, M., Irvin, M., Gupta, E., Gibbs, M., Kakar, T. S., Gannon, N. A., Arthurs, J. R., Fischer, D. L. & Ailawadhi, S., May 16 2017, (Accepted/In press) In : Chemotherapy. p. 295-300 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Disseminated Intravascular Coagulation
Colorectal Neoplasms
Hypersensitivity
Pharmaceutical Preparations
2 Citations (Scopus)

Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies

Shreders, A. J., Niazi, S. K., Hodge, D. O., Chimato, N. T., Kureti, M., Kirla, N., Agrawal, A., Swaika, A., Gustetic, E., Foster, R., Nelson, K. A., Jani, P., Chanan Khan, A. A. & Ailawadhi, S., Dec 7 2017, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Thermometers
Nonparametric Statistics
Health
Psychiatry
9 Citations (Scopus)

Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States

Jakubowiak, A. J., Houisse, I., Májer, I., Benedict, Á., Campioni, M., Panjabi, S. & Ailawadhi, S., Dec 2 2017, In : Expert Review of Hematology. 10, 12, p. 1107-1119 13 p.

Research output: Contribution to journalArticle

Quality-Adjusted Life Years
Multiple Myeloma
Dexamethasone
Cost-Benefit Analysis
Costs and Cost Analysis
10 Citations (Scopus)

Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States

Pelligra, C. G., Parikh, K., Guo, S., Chandler, C., Mouro, J., Abouzaid, S. & Ailawadhi, S., 2017, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

Multiple Myeloma
Cost-Benefit Analysis
Quality-Adjusted Life Years
Health Care Costs
Costs and Cost Analysis
6 Citations (Scopus)

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Paludo, J., Abeykoon, J. P., Kumar, S. K., Shreders, A., Ailawadhi, S., Gertz, M., Kourelis, T., King, R., Reeder, C. B., Leung, N., Kyle, R. A., Buadi, F. K., Habermann, T. M., Dingli, D. M., Witzig, T. E., Dispenzieri, A., Lacy, M., Go, R. S., Lin, Y., Gonsalves, W. & 5 others, Warsame, R., Lust, J. A., Rajkumar, S. V., Ansell, S. M. & Kapoor, P., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Confidence Intervals
Disease-Free Survival
47 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
4 Citations (Scopus)

Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?

Ailawadhi, S., Bhatia, K., Aulakh, S., Meghji, Z. & Chanan Khan, A. A., Jun 19 2017, (Accepted/In press) In : Current Hematologic Malignancy Reports. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Delivery of Health Care
Geographic Locations
Insurance Carriers
Vulnerable Populations
8 Citations (Scopus)

Extramedullary solitary plasmacytoma: Demonstrating the role of 18F-FDG PET imaging

Gautam, A., Sahu, K. K., Alamgir, A., Siddiqi, I. & Ailawadhi, S., Apr 1 2017, In : Journal of Clinical and Diagnostic Research. 11, 4, p. XD01-XD03

Research output: Contribution to journalArticle

Plasmacytoma
Fluorodeoxyglucose F18
Plasmas
Imaging techniques
Plasma Cells
28 Citations (Scopus)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D. M., Go, R. S., Lin, Y., Gonsalves, W., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Physical vapor deposition

Prevalence of BCL-2/J(H) Translocation in Healthy African Americans

Colon-Otero, G., Van Wier, S. A., Ahmann, G. J., Braggio, E. D., Albertie, M. L., Weis, J. A., Ailawadhi, S., Cerhan, J. R., Vishnu, P., Jorgensen, M. S., Foran, J. M., Thomas, C. S. & Fonseca, R., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 51-55 5 p.

Research output: Contribution to journalArticle

African Americans
Follicular Lymphoma
Lymphocytes
Polymerase Chain Reaction
DNA
11 Citations (Scopus)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis

Ailawadhi, S., Frank, R. D., Advani, P., Swaika, A., Temkit, M., Menghani, R., Sharma, M., Meghji, Z., Paulus, S., Khera, N. D., Hashmi, S. K., Paulus, A., Kakar, T. S., Hodge, D. O., Colibaseanu, D. T., Vizzini, M. R., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Stem Cells
Thalidomide
Transplants
3 Citations (Scopus)

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Dholaria, B., Patel, R. J., Sluzevich, J. C., Ailawadhi, S. & Roy, V., Sep 6 2017, (Accepted/In press) In : Annals of Hematology. p. 1-2 2 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Transplants
Subcutaneous panniculitis-like T-cell lymphoma
1 Citation (Scopus)

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

Vidisheva, A. P., Wang, J., Spektor, T. M., Bitran, J. D., Lutzky, J., Tabbara, I. A., Ye, J. Z., Ailawadhi, S., Stampleman, L. V., Steis, R. G., Moezi, M. M., Swift, R. A., Maluso, T. M., Udd, K. A., Eshaghian, S., Nassir, Y. & Berenson, J. R., Apr 28 2017, (Accepted/In press) In : Supportive Care in Cancer. p. 1-8 8 p.

Research output: Contribution to journalArticle

Retreatment
Peripheral Nervous System Diseases
Safety
Therapeutics
Bortezomib
11 Citations (Scopus)

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Epidemiology
Incidence
Survival
Prostate
13 Citations (Scopus)
Waldenstrom Macroglobulinemia
Up-Regulation
Mutation
Therapeutics
Phosphatidylinositol 3-Kinases
2018

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

Nurses
Workload
Safety
Drug Therapy
Nursing Staff
6 Citations (Scopus)

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Pharmacokinetics
Safety
Maximum Tolerated Dose
Clinical Trials, Phase I
gemcitabine
Cholangiocarcinoma
Cisplatin
Epidemiology
Survival
13 Citations (Scopus)

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Bendamustine Hydrochloride
6 Citations (Scopus)

Disease and outcome disparities in multiple myeloma: Exploring the role of race/ethnicity in the Cooperative Group clinical trials

Ailawadhi, S., Jacobus, S., Sexton, R., Stewart, A. K., Dispenzieri, A., Hussein, M. A., Zonder, J. A., Crowley, J., Hoering, A., Barlogie, B., Orlowski, R. Z. & Rajkumar, S. V., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 67.

Research output: Contribution to journalArticle

Multiple Myeloma
Clinical Trials
Anemia
Therapeutics
Survival